GLENVIEW STATE BANK TRUST DEPT. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
GLENVIEW STATE BANK TRUST DEPT. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2021$576,000
-4.5%
7,1530.0%0.18%
-10.2%
Q1 2021$603,000
+5.1%
7,153
+0.1%
0.20%
-2.0%
Q4 2020$574,000
-0.2%
7,1450.0%0.20%
-8.3%
Q3 2020$575,000
+4.0%
7,145
+11.2%
0.22%
-4.8%
Q2 2020$553,000
+5.9%
6,4230.0%0.23%
-8.8%
Q1 2020$522,000
-2.8%
6,4230.0%0.25%
+21.3%
Q4 2019$537,000
-4.4%
6,4230.0%0.21%
-8.4%
Q3 2019$562,000
+6.8%
6,4230.0%0.23%
+3.7%
Q2 2019$526,000
+0.6%
6,4230.0%0.22%
-2.2%
Q1 2019$523,000
+23.6%
6,4230.0%0.22%
+9.3%
Q4 2018$423,000
+5.0%
6,423
+23.0%
0.20%
+16.6%
Q3 2018$403,000
+4.7%
5,2230.0%0.18%
-1.7%
Q2 2018$385,000
+13.2%
5,2230.0%0.18%
+11.2%
Q1 2018$340,000
+0.9%
5,2230.0%0.16%
+3.2%
Q4 2017$337,000
+2.7%
5,2230.0%0.16%
-2.5%
Q3 2017$328,000
+3.5%
5,2230.0%0.16%
-1.9%
Q2 2017$317,000
+17.0%
5,2230.0%0.16%
+15.7%
Q1 2017$271,000
+16.8%
5,2230.0%0.14%
+11.1%
Q4 2016$232,000
-17.1%
5,223
+30.6%
0.13%
-26.3%
Q2 2015$280,000
+2.2%
4,0000.0%0.17%
+3.6%
Q1 2015$274,000
+20.7%
4,000
+22.7%
0.16%
+15.4%
Q4 2013$227,0003,2600.14%
Other shareholders
BAXTER INTL INC shareholders Q3 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders